Founded in 2015, Sotac Pharmaceuticals Limited is an integral part of the esteemed SOTAC group, headquartered in Gujarat. The company specializes in the manufacturing of pharmaceutical products, catering to various marketers through loan license or contract manufacturing arrangements. Its primary business model involves working on a principle-to-principle basis with diverse marketers.
SOTAC has built strong relationships, serving more than 162 corporate clients through loan license and contract manufacturing agreements. Leveraging its extensive experience in the pharmaceutical segment, the company continues to witness consistent growth, expanding its operations year after year.
In 2017, Sotac Pharmaceuticals established its state-of-the-art manufacturing facility, equipped with the capacity to produce 90 Crore tablets and 14 Crore capsules annually.
With the collective expertise of the Promoters, boasting over 59 years of experience in the pharmaceutical manufacturing industry, Sotac Pharmaceuticals Limited is flourishing and diversifying its presence across various horizons. Positioned as a reliable partner in the pharmaceutical sector, the company is committed to delivering high-quality products and expanding its impact in the market.
Sotac Pharmaceuticals Limited Stock Quote #
- Open: ₹115.05
- High – Low: ₹115.10 – ₹115.05
- Previous Close: ₹122.95
- Total Traded Value: 2,400
- Updated On: Jul 21, 2023 4:00 PM
Sotac Pharmaceuticals IPO Details #
| IPO Date | Mar 29, 2023 to Apr 3, 2023 |
| Listing Date | Apr 13, 2023 |
| Face Value | ₹10 per share |
| Price | ₹105 to ₹111 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Fresh Issue | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 150,000 shares Sunflower Broking |
Sotac Pharmaceuticals IPO Reservation #
| Anchor Investor Shares Offered | 853,200 (28.42%) |
| Market Maker Shares Offered | 150,000 (5.00%) |
| QIB Shares Offered | 571,800 (19.05%) |
| NII (HNI) Shares Offered | 428,400 (14.27%) |
| Retail Shares Offered | 998,400 (33.26%) |
| Total Shares Offered | 3,001,800 (100%) |
Sotac Pharmaceuticals IPO Anchor Investors Details #
Sotac Pharmaceuticals IPO Anchor Investors list
| Bid Date | Mar 28, 2023 |
| Shares Offered | 853,200 |
| Anchor Portion Size (In Cr.) | 9.47 |
| Anchor lock-in period end date for 50% shares (30 Days) | May 24, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Aug 18, 2023 |
Sotac Pharmaceuticals IPO Timetable (Tentative) #
Sotac Pharmaceuticals IPO opens on Mar 29, 2023, and closes on Apr 3, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Wednesday, 29 March 2023 |
| Closing Date | Monday, 3 April 2023 |
| Basis of Allotment | Monday, 10 April 2023 |
| Initiation of Refunds | Tuesday, 11 April 2023 |
| Credit of Shares to Demat | Wednesday, 12 April 2023 |
| Listing Date | Thursday, 13 April 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Apr 3, 2023 |
Sotac Pharmaceuticals IPO Lot Size #
The Sotac Pharmaceuticals IPO lot size is 1200 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹133,200 |
| Retail (Max) | 1 | 1200 | ₹133,200 |
| HNI (Min) | 2 | 2,400 | ₹266,400 |
| Lot Size Calculator | |||
Sotac Pharmaceuticals IPO Promoter Holding #
Mr. Sharadkumar Dashrathbhai Patel, Mr. Dineshkumar Babulal Gelot, Mr. Vishalkumar Devrajbhai Patel, Mr. Chetankumar Bachubhai Patel, and Mrs. Kiran Baldevbhai Jotania are the promoters of the company.
| Pre Issue Share Holding | 84.63% |
| Post Issue Share Holding |
Company Financials #
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-20 | 3,038.21 | 2,882.64 | 8.75 | 305.73 | 75.73 | 15.13 |
| 31-Mar-21 | 3,469.75 | 4,894.97 | -236.54 | 249.36 | 19.36 | 1,035.80 |
| 31-Mar-22 | 3,525.35 | 7,337.02 | 287.86 | 662.19 | 432.19 | 1,134.59 |
| 30-Sep-22 | 6,461.60 | 3,994.65 | 46.55 | 797.41 | 567.41 | 2,185.52 |
| Amount in ₹ Lakhs | ||||||
Key Performance Indicator #
| KPI | Values |
|---|---|
| P/E (x) | 132.14 |
| Market Cap (₹ Cr.) | 122.66 |
| ROE | 6.38% |
| ROCE | 19.03% |
| Debt/Equity | 2.74 |
Objects of the Issue #
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
- To Meet Working Capital Requirements
- Investment in Subsidiary
- Upgradation / Construction of Existing /New Building in the Existing Premises
- General Corporate Purpose
- To meet Public Issue Expenses
Sotac Pharmaceuticals IPO Subscription Status (Bidding Detail) #
The Sotac Pharmaceuticals IPO is subscribed 1.60 times on Apr 3, 2023 7:30:00 PM. The public issue subscribed 0.91 times in the retail category, 1.00 times in the QIB category, and 4.04 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 1.00 |
| NII | 4.04 |
| Retail | 0.91 |
| Total | 1.60 |
Total Application : 755 (1.30 times)
Sotac Pharmaceuticals IPO Prospectus #
- › Sotac Pharmaceuticals IPO DRHP
- › Sotac Pharmaceuticals IPO RHP
- › Anchor Investors in Sotac Pharmaceuticals IPO
Sotac Pharmaceuticals IPO Listing Details #
| Listing Date | Apr 13, 2023 |
| BSE Script Code | |
| NSE Symbol | SOTAC |
| ISIN | INE0O2D01012 |
| Final Issue Price | ₹111 per share |
Listing Day Trading Information #
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹111.00 |
| ₹115.00 |
| ₹115.00 |
| ₹120.75 |
| ₹120.75 |
Check IPO Performance…
Company Contact Information #
Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand Ahmedabad – 382110
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/
Sotac Pharmaceuticals IPO Registrar #
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sotac.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Sotac Pharmaceuticals IPO Lead Manager(s) #
Frequently Asked Questions #
When does the Sotac Pharmaceuticals IPO open and close? #
The Sotac Pharmaceuticals IPO opens on March 29, 2023, and closes on April 3, 2023.
What is the IPO price and face value of Sotac Pharmaceuticals IPO? #
The IPO price of Sotac Pharmaceuticals is set at ₹111 per equity share, and the face value is ₹10 per share.
What is the IPO size and lot size of Sotac Pharmaceuticals IPO? #
The Sotac Pharmaceuticals IPO size is ₹33.30 Crores, and the lot size is 1200 shares.
Where will Sotac Pharmaceuticals IPO be listed? #
Sotac Pharmaceuticals IPO will be listed on NSE SME on April 13, 2023.
What is the subscription status of Sotac Pharmaceuticals IPO? #
As of the latest update, the IPO has been subscribed 1.60 times, with Qualified Institutional Buyers (QIB) subscribing 1.00 times, Non-Institutional Investors (NII) subscribing 4.04 times, and Retail Individual Investors (RII) subscribing 0.91 times.
What are the objectives of the Sotac Pharmaceuticals IPO? #
The objectives of the Sotac Pharmaceuticals IPO are to meet working capital requirements, invest in subsidiaries, upgradation/construction of existing/new building in the existing premises, general corporate purposes, and meet public issue expenses.
What services does Sotac Pharmaceuticals provide? #
Sotac Pharmaceuticals is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company specializes in manufacturing a wide range of pharmaceutical products such as non-beta-lactam (general) tablets, capsules, syrup, and external preparations.
What is the basis of allotment for Sotac Pharmaceuticals IPO? #
The basis of allotment for Sotac Pharmaceuticals IPO is scheduled for April 10, 2023.
How can I check the allotment status of Sotac Pharmaceuticals IPO? #
The allotment status of Sotac Pharmaceuticals IPO will be available on April 10, 2023. You can check it online by visiting the IPO registrar’s website and entering either your PAN number, Application Number, or DP Client ID of the demat account.
Please note that the information provided here is based on the available data and may be subject to change. For the most up-to-date and accurate information, it is recommended to visit the official sources and financial portals directly.
